Infinity Bio
Baltimore, MD
Infinity Bio is a Circulating Antibody Repertoire Profiling service company, leveraging a novel technology, MIPSA (Molecular Indexing of Proteins (or Peptides) by Self Assembly) developed by Dr. H. Ben Larman, a pioneer in this field. Our various antigen libraries provide cost effective, comprehensive and quantitative analyses of antibody responses to infections, vaccinations, self-antigens and allergens. Our proprietary method allows for the rapid and flexible content customization. Infinity Bio can design and create customer specific peptide libraries against any target of choice.
infinitybio.comCompany Details
Founded
- 2023
Employees
- Between 10 - 50 employees
Raised
- $4,516,093
Headquarters Location
- Baltimore, MD
Public
- No
Acquired
- No
CEO
- Joy Nassif
Company Collections
These are collections Infinity Bio is a part of. Click on the collection name to view similar companies.